TAU PROTEINS

Details for Australian Patent Application No. 2002237296 (hide)

Owner AXON NEUROSCIENCE FORSCHUNGSUND ENTWICKLUNGS GMBH

Inventors NOVAK, Michal

Pub. Number AU-A-2002237296

PCT Pub. Number WO2002/062851

Priority A 175/2001 02.02.01 AT

Filing date 29 January 2002

Wipo publication date 19 August 2002

International Classifications

C07K 016/18 Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61K 039/395 Medicinal preparations containing antigens or antibodies - Antibodies

C12N 005/20 Undifferentiated human, animal or plant cells, e.g. cell lines - one of the fusion partners being a B lymphocyte

C07K 014/47 Peptides having more than 20 amino acids

G01N 033/577 Investigating or analysing materials by specific methods not covered by groups - involving monoclonal antibodies

G01N 033/68 Investigating or analysing materials by specific methods not covered by groups - involving proteins, peptides or amino acids

Event Publications

13 February 2003 Application Open to Public Inspection

  Published as AU-A-2002237296

12 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002237297-TAMPEREVIDENT CLOSURE

2002237295-NEW METHOD FOR GENOTYPE DETERMINATION